• Continued development and commercialization of natural antimicrobial technology
• Eco Nurture plant bio-stimulant progressing for New Zealand kiwifruit industry
• SuprCuvr hospital-grade disinfectant gaining traction in commercial settings

Skin Elements Limited, a researcher and developer of innovative proprietary SE Formula biotechnology, has reported its preliminary financial results for the year ended 30 June 2025. The company continued to focus on the development and commercialization of its natural antimicrobial technology, with key highlights including the progress of the Eco Nurture plant bio-stimulant for the New Zealand kiwifruit industry and the growing traction of the SuprCuvr hospital-grade disinfectant in commercial settings. The company also made progress with its PapayaActivs natural therapeutics skincare range and the Soléo Organics natural and organic sunscreen formulation. During the year, Skin Elements received R&D rebate funding and completed a rights issue to existing shareholders, raising additional capital. The company reported a decrease in loss from ordinary activities after tax and a decrease in EBITDA loss compared to the previous year.

The company expects to continue its focus on the development and commercialization of its natural antimicrobial technology, including the Eco Nurture plant bio-stimulant and the SuprCuvr hospital-grade disinfectant, during the 2026 financial year.